Retrospective Study
Copyright ©The Author(s) 2020.
World J Stem Cells. Jun 26, 2020; 12(6): 514-526
Published online Jun 26, 2020. doi: 10.4252/wjsc.v12.i6.514
Table 4 Effect of age and lesion size on clinical outcomes
Age (n = 125)
Lesion size (n = 125)
βtR2P value1βtR2P value1
IKDC
Pre-op-0.128-1.4290.0160.156-0.148-1.6610.0220.099
1 yr-0.095-1.0530.0090.294-0.025-0.2820.0010.779
2 yr-0.053-0.5930.0030.554-0.120-1.3390.0140.183
3 yr0.0490.5490.0020.5840.0240.2660.0010.791
WOMAC
Pre-op0.3273.8310.107< 0.0010.3053.5500.0930.001
1 yr0.1731.9450.0300.0540.0400.4400.0020.661
2 yr-0.005-0.055< 0.0010.9560.0520.5750.0030.566
3 yr-0.048-0.5320.0020.595-0.064-0.7160.0040.475
VAS
Pre-op0.1151.2860.0130.2010.3353.9430.112< 0.001
1 yr0.1141.2780.0130.2040.1131.2660.0130.208
2 yr0.0010.013<0.0010.9890.1121.2490.0130.214
3 yr-0.047-0.5190.0020.6050.1641.8420.0270.068